Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women-Reference-Cited by-同舟云学术

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women

Published:2008-01-23 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Wells George A¹,Cranney Ann²,Peterson Joan³,Boucher Michel⁴,Shea Beverley⁵,Welch Vivian⁶,Coyle Doug⁷,Tugwell Peter⁸

Affiliation:

1. University of Ottawa Heart Institute; Cardiovascular Research Reference Centre; Room H1-1 40 Ruskin Street Ottawa Ontario Canada K1Y 4W7

2. Ottawa Hospital; Division of Rheumatology; 1053 Carling Ave Ottawa Ontario Canada K1Y 4E9

3. Ottawa Civic Hospital / Loeb Research Institute; Clinical Epidemiology Unit; 1053 Carling Avenue Ottawa Ontario Canada K1Y 4E9

4. HTA Development Canadian Agency for Drugs and Technologies in Health (CADTH); 865 Carling Ave Suite 600 Ottawa Ontario Canada K1S 5S8

5. University of Ottawa; Institute of Population Health; 1 Stewart St. Room 312 Ottawa Ontario Canada K1N 6N5

6. University of Ottawa; Centre for Global Health, Institute of Population Health; 1 Stewart Street, Room 206 Ottawa Ontario Canada K1N 6N5

7. Ottawa Health Research Institute; Epidemiology and Community Medicine; 451 Smyth Rd. Ottawa Ontario Canada K1H 8M5

8. Ottawa Hospital; Centre for Global Health, Institute of Population Health, Department of Medicine; 1 Stewart Street Ottawa Ontario Canada K1N 6N5

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003376.pub3/fullpdf

Reference86 articles.

1. The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study;Herd;American Journal of Medicine,1997

2. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study;Ishida;American Journal of Medicine,2004

3. The effect of a modified etidronate cyclical regimen on postmenopausal osteoporosis: a four-year study;Lyritis;Clinical Rheumatology,1997

4. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up) [see comment] [erratum appears in J Clin Endocrinol Metab 1997 Nov;82(11):3740];Meunier;Journal of Clinical Endocrinology and Metabolism,1997

5. The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment;Montessori;Osteoporosis International,1997

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muscle loss and sarcopenia associated with physical function and functioning capacity in community-dwelling older women with bone loss;Japanese Journal of Physical Fitness and Sports Medicine;2024-08-01

2. Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women;Cochrane Database of Systematic Reviews;2024-04-09

3. Bisphosphonates for postmenopausal osteoporosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-09-28

4. Fracture risk after deprescription of bisphosphonates: Application of real-world data in primary care;Atención Primaria;2023-07

5. Decrease in osteoporotic fracture in the western Kitakyushu region by the STOP-Fx study;Journal of Bone and Mineral Metabolism;2023-05-29